Form 4: GLSI CEO Buys 10,600 Shares Under 10b5-1 Plan

Greenwich LifeSciences, Inc. CEO and CFO, Snehal Patel, acquired 10,600 shares of common stock at $8.43 per share, increasing beneficial ownership to 5,583,502 shares.

Summary

• Snehal Patel, who serves as CEO, CFO, Director, and 10% Owner of Greenwich LifeSciences, Inc. (GLSI), reported a transaction.
• The transaction involved the acquisition of 10,600 shares of Common Stock.
• The shares were purchased at a price of $8.43 per share.
• The transaction date was November 7, 2025.
• Following this transaction, Snehal Patel beneficially owns 5,583,502 shares of Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 8

Explanation: The purchase of a significant number of shares by the CEO, CFO, Director, and 10% owner, even under a 10b5-1 plan, signals strong insider confidence in the company's valuation and future performance.

Positives

• The CEO, CFO, Director, and 10% owner, Snehal Patel, increased their stake in the company, signaling strong insider confidence.
• The purchase, even if pre-planned under a 10b5-1 plan, represents a commitment by key management to the company's future value.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the reported transaction.

Industry Context

This insider transaction is specific to Greenwich LifeSciences, Inc. and does not directly reflect broader industry trends, though insider buying can be a general indicator of management's perception of value within their respective sectors.

Related Party Transactions

• Snehal Patel, who serves as CEO, CFO, Director, and 10% owner, purchased shares from the open market, which is a related party transaction by definition of insider trading.

Stakeholder Impact

• Shareholders may view this as a positive signal of management's belief in the company's value and future prospects.
• Employees may perceive increased stability and confidence from leadership regarding the company's direction.

Key Dates

Recommendation

The significant purchase of common stock by CEO and CFO Snehal Patel, who also serves as a Director and 10% owner, demonstrates insider confidence, even though it was executed under a pre-arranged Rule 10b5-1 plan. This commitment suggests management believes in the company's long-term value, making it a positive signal for investors to consider a 'buy' position.

Keywords

Greenwich LifeSciences, GLSI, Insider Purchase, Snehal Patel, Form 4, Stock Acquisition, CEO, CFO, Director, 10% Owner, 10b5-1 Plan